rs137854591
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_000397.4(CYBB):c.302A>G(p.His101Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H101Y) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000397.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYBB | NM_000397.4 | c.302A>G | p.His101Arg | missense_variant | 4/13 | ENST00000378588.5 | |
CYBB | XM_047441855.1 | c.-5A>G | 5_prime_UTR_variant | 3/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYBB | ENST00000378588.5 | c.302A>G | p.His101Arg | missense_variant | 4/13 | 1 | NM_000397.4 | P1 | |
CYBB | ENST00000696171.1 | c.206A>G | p.His69Arg | missense_variant | 3/12 | ||||
CYBB | ENST00000696172.1 | c.302A>G | p.His101Arg | missense_variant, NMD_transcript_variant | 4/6 | ||||
CYBB | ENST00000696170.1 | c.302A>G | p.His101Arg | missense_variant, NMD_transcript_variant | 4/12 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Granulomatous disease, chronic, X-linked, variant Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 1991 | - - |
Granulomatous disease, chronic, X-linked Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 28, 2019 | Variant summary: CYBB c.302A>G (p.His101Arg) results in a non-conservative amino acid change located in the Ferric reductase transmembrane component-like domain of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 182647 control chromosomes (gnomAD). c.302A>G has been reported in the literature in individuals affected with X-linked Chronic Granulomatous Disease (Bolscher_1991, Roos_1996, Zhou_2018, de Oliveira-Junior_2015). One publication (Bolscher_1991) reports disease in a female patient with apparent X-inactivation of the wild-type chromosome. These data indicate that the variant may be associated with disease. Functional studies investigating a different amino acid change at this codon (p.His101Leu) suggest that this histidine is critical for heme binding and protein function (Biberstine-Kinkade_2001). In addition, another variant, c.301C>T, affecting this same codon, H101Y, has also been reported to be associated with disease (HGMD). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Other:1
not provided, no classification provided | literature only | UniProtKB/Swiss-Prot | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at